BioCentury
ARTICLE | Clinical News

AAV-CFTR: Began a Phase I/II trial

January 2, 1996 8:00 AM UTC

Targeted Genetics Corp. (TGEN), Seattle, Wash. Product: AAV- CFTR, adeno-associated virus vector bearing the normal CF transmembrane conductance regulator (CFTR) gene Indication: Chronic sinusitis in ...